Search the Health Library
Get the facts on diseases, conditions, tests and procedures.
I Want To...
I Want To...
Find Research Faculty
Enter the last name, specialty or keyword for your search below.
School of Medicine
I Want to...
Shuli Xia, Ph.D.
Associate Professor of Neurology
Dr. Xia received her doctoral degree in biology from Johannes-Gutenberg University in Mainz, Germany in 1998. She had her post-doctoral training at Washington University School of Medicine in St. Louis, MO and Yale University School of Medicine in New Haven, CT before she came to the Kennedy Krieger Institute in 2002. She became a faculty member at the Kennedy Krieger Institute in 2006.
- Research Scientist
- Associate Professor of Neurology
Departments / Divisions
- Neurology - Kennedy Krieger Institute
- B.S., Sichuan University (China) (1991)
- Ph.D., Johannes-Gutenberg University - Fak Medicine - Mainz - F R G (407-32 Pr 1/71) (West Germany) (1998)
Research & Publications
Dr. Xia’s research focuses on the cellular and molecular biology of primary brain tumor malignancy. Over the past several years, Dr. Xia has studied the molecular and cellular mechanisms of cell death and cytotoxicity. She developed anti-tumor strategies to synergistically induce cancer cell death by combining death receptor ligands and other chemotherapeutic drugs.
Dr. Xia’s research has recently been expanded to the regulation of glioblastoma stem-like cells. She is interested in the mechanisms and molecular pathways involved in maintenance of glioblastoma stem cells. She has studied the effects of histone deacetylase inhibitors, retinoic acid, the transcriptional repressor KLF9 and hepatocyte growth factor in self-renewal and differentiation of glioblastoma stem-like cells.
Currently, Dr. Xia is interested in the function of the tyrosine receptor kinase EphB2 in glioblastoma stem cells. Dr. Xia and her colleague found that EphB2 has both tumor-promoting and tumor-suppressing effects in glioblastoma stem cells in vitro and in vivo. They are now identifying signaling pathways that mediate the dual-functions of EphB2 in glioblastoma stem cells.
- Woodard, C. L., Goodwin R. C., Wan J., Xia S., Newman R., Hu J., et al.(2013). Profiling the dynamics of a human phosphorylome reveals new components in HGF/c-Met signaling. PloS one. 8(9), e72671.
- Hu, S., Wan J., Su Y., Song Q., Zeng Y., Nguyen H. N., et al. (2013). DNA methylation presents distinct binding sites for human transcription factors. eLife. 2, e00726.
- Goodwin, R. C., Lal B., Zhou X., Ho S., Xia S., Taeger A., et al. (2010). Cyr61 mediates hepatocyte growth factor-dependent tumor cell growth, migration, and Akt activation. Cancer research. 70(7), 2932-41.
- Sun, P., Xia S., Lal B., Eberhart C. G., Quinones-Hinojosa A., Maciaczyk J., et al.(2009). DNER, an epigenetically modulated gene, regulates glioblastoma-derived neurosphere cell differentiation and tumor propagation. Stem cells (Dayton, Ohio). 27(7), 1473-86.
- Lal, B., Xia S., Abounader R., & Laterra J. (2005). Targeting the c-Met pathway potentiates glioblastoma responses to gamma-radiation. Clinical cancer research: an official journal of the American Association for Cancer Research. 11(12), 4479-86.